<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-ITMF000013510H160018E</udiDi>
    <basicUdiDi>B-ITMF000013510H160018E</basicUdiDi>
    <tradeName>HYAMIRA</tradeName>
    <deviceName>Hyamira syringe prefilled with hyaluronic acid 1,6%</deviceName>
    <manufacturerName>NYUMA PHARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000013510</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>H16001</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:47:15.582Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITMF00001351040233JW</udiDi>
    <basicUdiDi>B-ITMF00001351040233JW</basicUdiDi>
    <tradeName>HYAMIRA FORTE</tradeName>
    <deviceName>HYAMIRA FORTE</deviceName>
    <manufacturerName>NYUMA PHARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000013510</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>40233</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:47:14.785Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITMF00001351040232JU</udiDi>
    <basicUdiDi>B-ITMF00001351040232JU</basicUdiDi>
    <tradeName>HYAMIRA BASIC</tradeName>
    <deviceName>Hyamira basic</deviceName>
    <manufacturerName>NYUMA PHARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000013510</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>40232</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:47:13.983Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITMF00001351040231JS</udiDi>
    <basicUdiDi>B-ITMF00001351040231JS</basicUdiDi>
    <tradeName>HYAMIRA SOFT</tradeName>
    <deviceName>Hyamira Soft</deviceName>
    <manufacturerName>NYUMA PHARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000013510</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>40231</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:47:09.189Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-IT-MF000013510H2000188</udiDi>
    <basicUdiDi>B-IT-MF000013510H2000188</basicUdiDi>
    <tradeName>HYAMIRA</tradeName>
    <deviceName>Hyamira syringe prefilled with hyaluronic acid 2%</deviceName>
    <manufacturerName>NYUMA PHARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000013510</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>H20001</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:43:15.820Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-IT-MF000013510H200002MG</udiDi>
    <basicUdiDi>B-IT-MF000013510H200002MG</basicUdiDi>
    <tradeName>HYAMIRA</tradeName>
    <deviceName>Hyamira syringe prefilled with hyaluronic acid 2%</deviceName>
    <manufacturerName>NYUMA PHARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000013510</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>H200002</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:43:12.280Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-IT-MF-000013510H16002D2</udiDi>
    <basicUdiDi>B-IT-MF-000013510H16002D2</basicUdiDi>
    <tradeName>HYAMIRA</tradeName>
    <deviceName>Hyamira syringe prefilled with hyaluronic acid 1,6%</deviceName>
    <manufacturerName>NYUMA PHARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000013510</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>H16002</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:43:03.228Z</lastUpdated>
  </row>
</eudamedExport>